3rd Annual Inhalation & Respiratory Drug Products Summit
14-15

November 2019

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

About

Welcome to the 3rd edition of the Inhalation & Respiratory Drug Products Summit on November 14-15, 2019, in Vienna, Austria. This Summit brings together experts from pharmaceutical and biotech industries, as well as manufacturers, academia and regulatory agencies, with the highest level of expertise in the respiratory field. Besides sharing best practices, this event offers a valuable opportunity for network¬ing and partnering with businesses of diverse sizes and types. The conference covers a wide spectrum of topics including an overview and...

Welcome to the 3rd edition of the Inhalation & Respiratory Drug Products Summit on November 14-15, 2019, in Vienna, Austria. This Summit brings together experts from pharmaceutical and biotech industries, as well as manufacturers, academia and regulatory agencies, with the highest level of expertise in the respiratory field. Besides sharing best practices, this event offers a valuable opportunity for network¬ing and partnering with businesses of diverse sizes and types. The conference covers a wide spectrum of topics including an overview and emerging trends of inhalation and respiratory drug products, formulation of inhaled therapies, nasal drug delivery, inhalation devices and respiratory drug products analytics and tools. We look forward to welcoming you this November in Vienna!

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists, Chemists and Engineers specialising in:

  • Connective Health
  • Drug Delivery
  • Formulation Development
  • Inhaled Dosage Systems
  • Medical Devices & Injectors
  • Particles Characterisation
  • Product Development
  • QA/QC
  • Regulatory Affairs
  • Respiratory Medicines
  • Risk Management
  • Device Engineering & Design
  • E-health Inhalation
  • Generics & Respiratory
  • Marketing & Business Development
  • New Delivery Technologies
  • Process Development
  • Pulmonary Pharmacology & Therapeutics
  • R&D
  • Respiratory Drug Development & Manufacturing
  • Respiratory Pharmacology
  • Scientific Research
Key Practical Learning Points of the Summit

Inhalation and respiratory drug development
Scientific research of inhalation medicine
Inhalation drug delivery
Inhalation devices development and engineering
Drug delivery innovation respiratory pharmacology
Medical devices and injectors
Respiratory R&D
E-health inhalation drug delivery technologies
Inhaled dosage systems connective health
Pulmonary disease metered dose inhaler development
Respiratory drug products analytics
Speakers
Dr. Felix Weiland, DE

Head of Combination Product Development

Boehringer Ingelheim microParts GmbH

Dr. Stefan Leiner, DE

Chemical-Pharmaceutical Expert

Boehringer Ingelheim

Dr. Frank Thielmann, CH

PMO & Operational Excellence Platform Leader, Biologics

Novartis

J. Ignasi Escamilla, ES

Inhalation & Sterile Technologies Manager / Pharmaceutical Development

Ferrer

Univ.-Prof. Dr. Sven Stegemann, DE

Professor for Patient Centric Drug Development & Manufacturing

Graz University of Technology

Dr. Gerhard Pohlmann, DE

Fraunhofer Institute for Toxicology & Experimental Medicine

Translational Medical Engineering

Prof. Ben Forbes, UK

Professor in Pharmaceutics

King's College London

Dr. Peter Daley-Yates, UK

Director Clinical Pharmacology

GSK

Robert Ives, UK

Investigator & Associate Fellow

GSK

Diana A. Fernandes, PT

Inhaled BioPharmaceutical Development Scientist

Hovione

David Roe, CH

Global Technical Steward MS&T Medical Devices & Combination Products

Novartis

Andrew Dundon, UK

CEO

Pharmechceutics Ltd.

Annual

Events

Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

"